JPMorgan reiterated an Overweight rating and $28 price target on IMAX Corporation (NYSE: IMAX) following results.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE